|
Index of reports
> Cases resulting in a serious event (133)
> Cases with Drug Exposure During Pregnancy (37)
Below is the selection of adverse event reports related to Retrovir (Zidovudine) that includes cases resulting in a serious event where reactions include drug exposure during pregnancy.
Reports 1 - 25 of 37 Next >>
Adverse event in receiving Retrovir (Zidovudine)
Reported by a individual with unspecified qualification from United States on 2007-10-19
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Hypospadias
Suspect drug(s):
Viracept
Administration route: Oral
Indication: HIV Infection
Videx
Sustiva
Epivir
Norvir
Retrovir
Indinivir Sulfate
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-07-30
Patient: female, weighing 3.9 kg (8.6 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Drug Administration Error, Accidental Overdose
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir (Zidovudine)
Other drugs received by patient: Zidovudine
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-07-24
Patient: male, weighing 3.4 kg (7.4 pounds)
Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Drug Exposure During Pregnancy, Congenital Anomaly, Cryptorchism, Abdominal Distension
Suspect drug(s):
Viracept
Dosage: daily dose:2500mg
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-06-01
Combivir
Dosage: daily dose:600mg
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-06-01
Kaletra
Dosage: daily dose:600mg
Indication: HIV Infection
Retrovir
Dosage: daily dose:600mg
Indication: HIV Infection
Start date: 2004-06-01
End date: 2004-07-20
Viread
Dosage: daily dose:300mg
Indication: HIV Infection
Start date: 2004-06-01
End date: 2004-07-20
Other drugs received by patient: Folic Acid
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-29
Patient: male, weighing 2.8 kg (6.2 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Combivir
Indication: Antiviral Prophylaxis
Start date: 2005-02-17
End date: 2005-04-06
Retrovir
Dosage: 1.1ml twice per day
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 2005-04-06
End date: 2005-05-17
Other drugs received by patient: Retrovir; Kaletra
Adverse event in receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-25
Patient:
Adverse reactions / side effects: Agitation, Overdose, Body Temperature Increased, Drug Exposure During Pregnancy, Abdominal Distension, Sneezing, Feeding Disorder Neonatal, Faecaloma
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Indication: HIV Infection
Retrovir
Indication: HIV Infection
Epivir
Administration route: Oral
Indication: Antiviral Prophylaxis
Retrovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Morphine
Viracept
Indication: HIV Infection
Viracept
Administration route: Oral
Indication: Antiviral Prophylaxis
Adverse event in 28 year old female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-25
Patient: 28 year old female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Drug Dependence, Treatment Noncompliance
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Retrovir
Administration route: Oral
Indication: HIV Infection
Viracept
Administration route: Oral
Indication: HIV Infection
Morphine
Administration route: Oral
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-06-18
Patient: female, weighing 2.6 kg (5.7 pounds)
Adverse reactions / side effects: Metabolic Acidosis, Drug Exposure During Pregnancy, Atrioventricular Block Complete, Patent Ductus Arteriosus, Heat Rash, Ventricular Septal Defect, Coarctation of THE Aorta
Suspect drug(s):
Retrovir (Zidovudine)
Other drugs received by patient: Kaletra; Didanosine
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-06-14
Patient: female
Adverse reactions / side effects: Electroencephalogram Abnormal, Cerebral Disorder, Drug Exposure During Pregnancy, Rhinitis, Neutropenia, Foetal Growth Retardation, Anaemia Macrocytic
Adverse event resulted in: hospitalization
Suspect drug(s):
Zerit
Dosage: ongoing gestational weeks 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Videx
Dosage: ongoing at gestational weeks 2 through 10
Indication: HIV Infection
Start date: 1997-05-29
End date: 1997-07-01
Fortovase
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Retrovir
Dosage: initiated at gestational week 10
Indication: HIV Test Positive
Start date: 1997-07-01
End date: 1998-01-19
Retrovir
Dosage: infusion at delivery
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Crixivan
Dosage: ongoing gestational week 2 through 10
Indication: HIV Test Positive
Start date: 1997-05-29
End date: 1997-07-01
Epivir
Dosage: initiated at gestational week 29
Indication: HIV Test Positive
Start date: 1997-11-12
End date: 1998-01-19
Epivir
Dosage: 6 week course after birth
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 1998-01-01
End date: 1998-03-01
Adverse event in 28 month old female receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-29
Patient: 28 month old female
Adverse reactions / side effects: Electroencephalogram Abnormal, Drug Exposure During Pregnancy, Nervous System Disorder, Nuclear Magnetic Resonance Imaging Abnormal, Pregnancy
Adverse event resulted in: hospitalization
Suspect drug(s):
Zerit
Dosage: from the 26th week of gestation.
Start date: 1998-01-14
Videx
Dosage: from the 26th week of gestation.
Start date: 1998-01-14
Retrovir
Dosage: from the 13th week to the 26th week of gestation.
Start date: 1997-10-01
End date: 1998-01-01
Invirase
Dosage: from the 17th week to the end of pregnancy.
Start date: 1997-11-01
End date: 1998-04-01
Norvir
Dosage: from the 17th week to the end of pregnancy.
Start date: 1997-11-01
End date: 1998-04-01
Epivir
Dosage: from the 17th week of gestation to the 26th week.
Start date: 1997-11-01
End date: 1998-04-01
Epivir
Dosage: syrup
Administration route: Oral
Start date: 1997-11-01
End date: 1998-01-01
Retrovir
Dosage: syrup
Administration route: Oral
Start date: 1997-10-01
End date: 1998-01-01
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-15
Patient: male, weighing 3.4 kg (7.4 pounds)
Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Drug Exposure During Pregnancy, Congenital Anomaly, Cryptorchism, Abdominal Distension
Suspect drug(s):
Viracept
Dosage: daily dose:2500mg
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-07-20
Combivir
Dosage: daily dose:600mg
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-06-01
Kaletra
Dosage: daily dose:600mg
Indication: HIV Infection
Retrovir
Dosage: daily dose:600mg
Indication: HIV Infection
Start date: 2004-06-01
End date: 2004-07-20
Viread
Dosage: daily dose:300mg
Indication: HIV Infection
Start date: 2004-06-01
End date: 2004-07-20
Other drugs received by patient: Folic Acid
Adverse event in receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-05-08
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Coarctation of THE Aorta
Suspect drug(s):
Retrovir (Zidovudine)
Other drugs received by patient: Kaletra; Didanosine
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-08
Patient: male, weighing 3.4 kg (7.4 pounds)
Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Drug Exposure During Pregnancy, Congenital Anomaly, Cryptorchism, Abdominal Distension
Suspect drug(s):
Viracept
Dosage: daily dose:2500mg
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-07-20
Combivir
Dosage: daily dose:600mg
Indication: HIV Infection
Start date: 2004-01-30
End date: 2004-06-01
Kaletra
Dosage: daily dose:600mg
Indication: HIV Infection
Retrovir
Dosage: daily dose:600mg
Indication: HIV Infection
Start date: 2004-06-01
End date: 2004-07-20
Viread
Dosage: daily dose:300mg
Indication: HIV Infection
Start date: 2004-06-01
End date: 2004-07-20
Other drugs received by patient: Folic Acid
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-04
Patient: male, weighing 3.4 kg (7.4 pounds)
Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Drug Exposure During Pregnancy, Congenital Anomaly, Cryptorchism, Abdominal Distension
Suspect drug(s):
Viracept
Dosage: daily dose:2500mg-freq:unknown
Administration route: Oral
Indication: HIV Test Positive
Start date: 2004-01-30
End date: 2004-06-01
Truvada
Dosage: daily dose:300mg-freq:unknown
Administration route: Oral
Indication: HIV Test Positive
Start date: 2004-06-01
End date: 2004-07-20
Combivir
Dosage: daily dose:600mg-freq:unknown
Administration route: Oral
Indication: HIV Test Positive
Start date: 2004-01-30
End date: 2004-06-01
Kaletra
Dosage: daily dose:600mg-freq:unknown
Administration route: Oral
Indication: HIV Test Positive
Retrovir
Dosage: daily dose:600mg-freq:unknown
Administration route: Oral
Indication: HIV Test Positive
Start date: 2004-06-01
End date: 2004-07-20
Other drugs received by patient: Folic Acid
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United Kingdom on 2007-05-03
Patient: male
Adverse reactions / side effects: Abdominal Hernia, Cardiac Murmur, Drug Exposure During Pregnancy, Congenital Anomaly, Cryptorchism, Abdominal Distension
Suspect drug(s):
Combivir
Dosage: 600mg per day
Start date: 2004-01-30
End date: 2004-06-01
Truvada
Dosage: 300mg per day
Start date: 2004-06-01
End date: 2004-07-20
Viracept
Dosage: 2500mg per day
Start date: 2004-01-30
End date: 2004-06-01
Kaletra
Dosage: 600mg per day
Start date: 2004-06-01
Retrovir
Dosage: 600mg per day
Start date: 2004-06-01
End date: 2004-07-20
Other drugs received by patient: Folic Acid
Adverse event in 4 year old female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-04-19
Patient: 4 year old female, weighing 21.6 kg (47.5 pounds)
Adverse reactions / side effects: Abdominal Pain, White Blood Cell Count Decreased, Vomiting, Tachycardia, Pyrexia, Blood Fibrinogen Increased, Pallor, Acute Lymphocytic Leukaemia, Haemoglobin Decreased, Diarrhoea, C-Reactive Protein Increased, Drug Exposure During Pregnancy, Ecchymosis, Blood Sodium Decreased, Asthenia
Adverse event resulted in: disablity
Suspect drug(s):
Combivir
Indication: Antiviral Prophylaxis
Start date: 2002-07-12
End date: 2002-10-01
Retrovir
Dosage: .75ml four times per day
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 2002-10-12
End date: 2002-11-26
Adverse event in receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-17
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Stillbirth, Foetal Malformation
Adverse event resulted in: death
Suspect drug(s):
Retrovir
Dosage: 500mg per day
Indication: HIV Infection
Videx
Dosage: 250mg per day
Indication: HIV Infection
Viramune
Indication: HIV Infection
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-11
Patient: male, weighing 2.9 kg (6.4 pounds)
Adverse reactions / side effects: Trisomy 21, Atrial Septal Defect, Drug Exposure During Pregnancy, Patent Ductus Arteriosus
Suspect drug(s):
Combivir
Dosage: 2tab per day
Indication: HIV Infection
Start date: 2006-09-28
End date: 2006-10-04
Trizivir
Dosage: 2tab per day
Indication: HIV Infection
Start date: 2006-09-21
End date: 2006-09-21
Retrovir
Dosage: 476mg per day
Indication: HIV Infection
Start date: 2006-10-04
End date: 2006-10-04
Adverse event in receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-03
Patient:
Adverse reactions / side effects: Vertical Infection Transmission, Drug Exposure During Pregnancy, Human Immunodeficiency Virus Transmission, Maternal Condition Affecting Foetus, Failure TO Thrive, Hepatosplenomegaly
Suspect drug(s):
Retrovir
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Epivir
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Nevirapine
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Quinine Sulfate
Dosage: transplacentary
Indication: Plasmodium Falciparum Infection
Adverse event in receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-04-03
Patient:
Adverse reactions / side effects: Caesarean Section, Lymphadenopathy, Drug Exposure During Pregnancy, HIV Infection, Human Immunodeficiency Virus Transmission, Failure TO Thrive, Hepatosplenomegaly
Suspect drug(s):
Retrovir
Indication: Antiviral Prophylaxis
Retrovir
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Nevirapine
Dosage: single dose
Indication: Antiviral Prophylaxis
Didanosine
Indication: Antiviral Prophylaxis
Didanosine
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Nevirapine
Dosage: transplacentary
Indication: Antiviral Prophylaxis
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-02
Patient: male, weighing 1.4 kg (3.1 pounds)
Adverse reactions / side effects: Congenital Hydronephrosis, Congenital Musculoskeletal Anomaly, Umbilical Cord Abnormality, Drug Exposure During Pregnancy, Patent Ductus Arteriosus, Arachnoid Cyst, Interruption of Aortic Arch, Atrioventricular Septal Defect
Suspect drug(s):
Trizivir
Dosage: 2tab per day
Indication: HIV Infection
Start date: 2006-03-30
End date: 2006-05-12
Retrovir
Dosage: 423mg per day
Indication: HIV Infection
Start date: 2006-05-10
End date: 2006-05-10
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-03-30
Patient: female, weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Necrotising Enterocolitis Neonatal
Adverse event resulted in: life threatening event
Suspect drug(s):
Retrovir
Dosage: 1.6mg twice per day
Indication: Antiviral Prophylaxis
Start date: 2007-01-19
End date: 2007-01-26
Retrovir
Dosage: 2mg twice per day
Administration route: Oral
Start date: 2007-01-26
End date: 2007-02-08
Other drugs received by patient: Antiretroviral Medications
Adverse event in receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-03-26
Patient:
Adverse reactions / side effects: Drug Exposure During Pregnancy, Coarctation of THE Aorta
Suspect drug(s):
Retrovir (Zidovudine)
Other drugs received by patient: Kaletra; Didanosine
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a physician from Japan on 2007-03-05
Patient: female
Adverse reactions / side effects: Cleft LIP and Palate, Drug Exposure During Pregnancy, Anaemia, Drug Exposure VIA Breast Milk
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Indication: HIV Infection
Start date: 2004-02-13
Retrovir
Dosage: 400mg per day
Indication: HIV Infection
Start date: 2004-02-13
Viracept
Dosage: 2500mg per day
Indication: HIV Infection
Start date: 2004-02-13
Retrovir
Dosage: .46ml four times per day
Administration route: Oral
Start date: 2004-06-22
End date: 2004-08-03
Other drugs received by patient: Lopemin; Ferrum; Utemerin
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-27
Patient: female
Adverse reactions / side effects: Dysmorphism, Drug Exposure During Pregnancy
Adverse event resulted in: disablity
Suspect drug(s):
Viracept
Administration route: Oral
Indication: HIV Test Positive
Retrovir
Administration route: Oral
Indication: HIV Test Positive
Combivir
Dosage: text:unknown-freq:unknown
Administration route: Oral
Indication: HIV Test Positive
Adverse event in receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from South Africa on 2007-02-21
Patient:
Adverse reactions / side effects: Nose Deformity, Drug Exposure During Pregnancy, Premature Baby, Talipes, Limb Malformation
Suspect drug(s):
Epivir
Dosage: 150mg per day
Indication: HIV Infection
Start date: 2005-02-23
Retrovir
Dosage: 600mg per day
Indication: HIV Infection
Start date: 2005-12-29
Zerit
Dosage: 80mg per day
Indication: HIV Infection
Start date: 2005-02-23
End date: 2005-12-29
Sustiva
Dosage: 600mg per day
Indication: HIV Infection
Start date: 2005-02-23
End date: 2005-12-29
Viramune
Dosage: 400mg per day
Indication: HIV Infection
Start date: 2005-12-29
Page 1 Next >>
|
